4.8 Article

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

期刊

NATURE
卷 595, 期 7869, 页码 707-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41586-021-03677-y

关键词

-

资金

  1. Swiss National Science Foundation (SNSF) [31CA30 196046, 31CA30 196267]
  2. European Union [101003688]
  3. University of Basel
  4. ETH Zurich
  5. National Institute of General Medical Sciences [R01GM120553]
  6. National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C]
  7. Pew Biomedical Scholars Award
  8. Burroughs Wellcome Fund
  9. NIAID [R01AI141707, F30AI149928]
  10. Instituto de Salud Carlos III project [COV20/00140]
  11. Spanish National Research Council
  12. MICIN [ERC StG 638553, BFU2017-89594R]
  13. Swiss National Science Foundation (SNF) [31CA30_196267, 31CA30_196046] Funding Source: Swiss National Science Foundation (SNF)
  14. OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1AI158186] Funding Source: NIH RePORTER

向作者/读者索取更多资源

A variant of SARS-CoV-2, 20E (EU1), was identified in Spain in early summer 2020 and later spread across Europe. Despite not showing increased transmissibility, the variant's success can be attributed to rising incidence in Spain, resumption of travel, and lack of effective screening and containment measures. Travel played a significant role in introducing the variant multiple times to European countries during the summer, undermining local efforts to prevent SARS-CoV-2 infection.
Following its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail(3-5). Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant's success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据